Showing 5001-5010 of 6036 results for "".
- Verana Health Announces Real-World Data and Data Science Collaboration Agreement with Janssenhttps://modernod.com/news/verana-health-announces-real-world-data-and-data-science-collaboration-agreement-with-janssen/2478805/Verana Health announced a research collaboration agreement with Janssen Research & Development (Janssen). The research collaboration will focus on curating real-world data and driving data science applications in the areas of ophthalmology and urology. Financial terms of the agreement
- Neurophth Therapeutics Appoints Qiutang Li, PhD, as Chief Scientific Officerhttps://modernod.com/news/neurophth-therapeutics-appoints-qiutang-li-phd-as-chief-scientific-officer/2478800/Wuhan Neurophth Biotechnology, a developer of AAV-delivered gene therapies for the treatment of ocular diseases, announced the appointment of Qiutang Li, PhD, as Chief Scientific Officer. She will be mainly responsible for the company’s global R&D, IND portfolio strategy, and the establ
- Center For Sight is the First Practice Worldwide to Offer the OptiBlue IOLhttps://modernod.com/news/center-for-sight-is-the-first-practice-worldwide-to-offer-the-optiblue-iol/2478793/Center For Sight, which operates 14 eye clinics and surgery centers in Southwest Florida, is the first eye care practice to offer the new OptiBlue IOLs (Johnson & Johnson Vision), an advanced intraocular lens technology that filters violet light to improve contrast and clarity for cataract pa
- Merck Shuts Down Covid Vaccine Program After Lackluster Datahttps://modernod.com/news/merck-shuts-down-covid-vaccine-program-after-lackluster-data/2478791/Merck is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines, according to a Bloomberg
- Genentech’s Faricimab Meets Primary Endpoint in Two Global Phase 3 Studies in Wet AMDhttps://modernod.com/news/genentechs-faricimab-meets-primary-endpoint-in-two-global-phase-3-studies-in-wet-amd/2478792/Genentech announced positive topline results from two identically designed global phase 3 studies, TENAYA and LUCERNE, evaluating its investigational bispecific antibody, faricimab, in people living with wet age-related macular degeneration (AMD). Both studies met their primary endpoint and showe
- Ace Vision Group Closes Series A Stock Round to Advance Ophthalmic Technologieshttps://modernod.com/news/ace-vision-group-closes-series-a-stock-round-to-advance-ophthalmic-technologies/2478790/Ace Vision Group announced that it closed a Series A preferred stock round totaling $13.3 million ($3.3 million oversubscribed) to continue development and commercialization of its VisioLite Ophthalmic Laser, a touchless therapeutic device being developed for the treatment of age-related vision d
- Lilly’s Bamlanivimab Cuts Risk of COVID-19 By Up to 80% at Nursing Homeshttps://modernod.com/news/lillys-bamlanivimab-cuts-risk-of-covid-19-by-up-to-80-at-nursing-homes/2478788/Eli Lilly announced Thursday that in a phase 3 study, bamlanivimab was shown to significantly reduce the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities. The findings from the BLAZE-2 COVID-19 prevention trial suggest the risk was decreased by up to
- New Global Survey Underscores Need for Myopia Education and Evidence-Based Approacheshttps://modernod.com/news/new-global-survey-underscores-need-for-myopia-education-and-evidence-based-approaches/2478783/Recently released global survey results from CooperVision underscore a gap between the concern of eye care professionals and the understanding of parents regarding the growing myopia epidemic and the impact myopia can have on future eye health. Four in five eye care professionals (82%) worry that
- VSY Biotechnology Introduces Protectalon DUO Kithttps://modernod.com/news/vsy-biotechnology-introduces-protectalon-duo-kit/2478778/VSY Biotechnology has introduced the Protectalon DUO Kit, which is designed to help eye care professionals meet their OVD needs at different stages of cataract surgery with a single kit. The Protectalon DUO Kit features a Dual Pack containing one unit cohesive (14 mg/mL, 1.1 mL) and one un
- EyeCare Partners Acquires of Several Oklahoma-Based Independent Ophthalmology Practiceshttps://modernod.com/news/eyecare-partners-acquires-of-several-oklahoma-based-independent-ophthalmology-practices/2478776/EyeCare Partners has acquired multiple independent ophthalmology practices in Oklahoma City. The deal includes four ophthalmologists from three individual practices with six office locations and two ambulatory surgery centers. Epic Vision, Cataract Institute of Oklahoma, Precision Vision, and Eye